Skip to main content
Full access
Letter
Published Online: 1 August 1999

Lithium-Treated Mood Disorders, Paroxysmal Rhinorrhea, and Mesial Temporal Lobe Epilepsy

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
SIR: We report two cases of carbamazepine-responsive mood disorders that are inferred to be secondary to mesial temporal lobe epilepsy. Paroxysmal rhinorrhea, exacerbated or invoked by lithium use, was prominent in the clinical history.

Case Reports

Case 1. A 48-year-old woman was seen for a rapid-cycling bipolar II disorder, which was partially responsive to 2 years of lithium. Lithium was effective in controlling shoplifting and major discrete cycles. Residual problems were mild cycling, anergia, anhedonia, 30-pound weight gain, intense body dysmorphia with occasional bulimia, and poor concentration.
Her full history suggested partial epilepsy. Sensations of or actual postural instability occurred suddenly 1 or 2 times a week and usually lasted 4 to 6 seconds. If standing at the time, she would sit down; however, often these experiences would occur while she was in bed. Nausea attacks, constipation, and unilateral headache were frequent. Along with numerous gaps in her childhood memories, she was frequently troubled by vague and bizarre improbable dreams of sexual abuse by her mother in her childhood. For 10 years she had experienced 3- to 5-second periods when she would read or hear a common word and would be unable to recognize its meaning. Her EEG was reported as abnormal secondary to irregular slowing, sometimes sharply contoured, in the left temporal area. MRI was unremarkable.
Lithium discontinuation immediately led to a reduction in the frequency of a previously unreported, unexplained paroxysmal rhinorrhea. Treatment with carbamazepine (augmented with low-dose valproic acid) has essentially eliminated presenting symptoms over 1 year of follow-up. Occasionally, perhaps monthly, the patient will experience a brief 2- to 3-hour period with rhinorrhea, restlessness, mood elevation, and logorrhea.
Case 2. A 38-year-old male prison inmate was seen for follow-up of chronic depression, refractory to adequate doses of doxepin and nortriptyline. Ten percent of his time was spent in severe but remitting melancholic depressions of a few days' duration. His medical history was significant for atypical chest pain requiring frequent, inconclusive emergency room evaluations.
Lithium, at a blood level of 0.7, resulted in marked mood stability, with one mild brief mania and depression over a 6-month period. Concurrent with lithium use, however, came unpredictable neurological events: sudden attacks of profuse rhinorrhea (“they drown you”), diarrhea, and disequilibrium without dizziness. Ultimately, the patient was found collapsed in his cell. Prior to his collapse, he experienced sensations of nausea and of being unable to initiate breathing, which progressed over a period of 30 minutes. Commands by the guards could, however, initiate voluntary breathing. Hospital cardiac and neurological evaluation (without a surface EEG) was unremarkable.
He has been maintained on carbamazepine, without chest pain or mood disturbance, over a 6-month period.

Discussion

Evidence for intermittent rhinorrhea as a manifestation of mesial temporal lobe epilepsy has been accumulating recently, based on observations of nose-wiping behavior during video-monitored ictal events.1,2 Consistent with our experience, lithium clearly has proconvulsive effects in case series of temporal lobe epilepsies.3,4 The hypothesis needing to be examined is whether paroxysmal vasomotor rhinitis, with or without interictal epileptiform discharges on the surface EEG,5 implies the need for anticonvulsant treatment.

References

1.
Rajan AB, Baker NS, Agostini MA, et al: Seizure lateralization and localization by nose-wiping behavior (abstract). Neurology 1998; 50:A396
2.
Leutmezer F, Serles W, Aull S, et al: Post-ictal nose-wiping: a new lateralizing sign in temporal lobe CPS (abstract). Epilepsia 1998; 39:S71
3.
Jus A, Villeneuve A, Gautier J, et al: Influence of lithium carbonate on patients with temporal epilepsy. Can Psychiatr Assoc J 1973; 18:77–78
4.
Bell AJ, Cole A, Eccleston D, et al: Lithium neurotoxicity at normal therapeutic levels. Br J Psychiatry 1993; 162:689–692
5.
Monroe RR: Episodic behavioral disorders and limbic ictus. Compr Psychiatry 1985; 26:466–479

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 414 - 415
PubMed: 10440025

History

Published online: 1 August 1999
Published in print: August 1999

Authors

Affiliations

Jon Berner, M.D., Ph.D.
Woodinville, WA

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share